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Background and Purpose: We tested the hypothesis that inhibition of nitric oxide synthase activity in brain before ischemia alters cerebral blood flow and decreases brain injury after 4 hours of middle cerebral artery occlusion in cats.
Methods: Halothane-anesthetized cats underwent 4 hours of left middle cerebral artery occlusion after they were randomly assigned to receive either intravenous Nw-nitro-L-arginine methyl ester, at a dose that completely inhibited cortical nitric oxide synthase activity (10 mg/kg, n=10), or an equal volume of diluent (10 mL saline, n= 10). Serial blood flow measurements were made with radiolabeled microspheres, and injury volume was measured by triphenyltetrazolium staining.
Results: Blood flow to caudate nucleus and inferior temporal cortex decreased to the same extent in both groups during middle cerebral artery occlusion. Somatosensory evoked potential amplitude was reduced to less than 10% of baseline values in both groups. Injury volume of ipsilateral caudate nucleus in cats pretreated with nitroarginine (52±5%, mean±SE) was less (P<.05) compared with the saline group (80±4%), whereas ipsilateral cerebral hemispheric injury volume was similar between the two groups (30±6% and 32±4% of hemisphere in saline and nitroarginine groups, respectively).
Conclusions: These results suggest that inhibition of nitric oxide synthase decreases caudate injury volume at 4 hours of middle cerebral artery occlusion without an alteration in distribution of cerebral blood flow. (Stroke. 1993; 24:1717 -1724 KEY WORDs * cerebral arteries * cerebral blood flow * evoked potentials, somatosensory nitric oxide * cats E pxperimental evidence has demonstrated a role for nitric oxide (NO) or NO-containing compounds in relaxing vascular smooth muscle,' inhibiting platelet aggregation and adhesion,2 and mediating the cytotoxic effects of macrophages and neutrophils.3 Although in normal brain NO seems to be a nontoxic mediator of cerebral vasodilation,4 recent data suggest that NO may have neurotoxic effects if present in abnormally high concentrations.5-7 In endothelium and brain, ionized calcium is the intracellular messenger initiating the reduced nicotinamide-adenine dinucleotide-dependent oxidation of arginine to produce NO.8 9 It is well known that cerebral ischemia causes Regional CBF was measured with radiolabeled microspheres (16±0.5 ,m diameter; Du Pont-NEN Products, Boston, Mass) using the reference withdrawal method.19 Six radioactive isotopes ("3Gd, "14In, ll'Sn, 103Ru, 'Nb, 46Sc) were injected in random sequence in each animal. Approximately 1.5 x 106 microspheres were injected into the left atrium over a 20-second period, followed by a 5-mL saline flush. The reference blood sample was withdrawn from the aorta at 1.94 mL/min beginning 30 seconds before the injection and continuing for 90 seconds after the saline flush.
Four additional cats were used to determine the optimal dose of L-NAME to produce 100% inhibition of NO synthase within 60 minutes of administration and lasting for the 4-hour experimental protocol. Cats were prepared in a fashion identical to that of the injury volume protocol except that blood flow and injury volume were not measured. Cats received either saline, 1, 5, or 10 mg/kg L-NAME intravenously, and brain samples were taken through a craniotomy before drug tration. Brain homogenates were analyzed for maximal NO synthase activity by measuring conversion of 'Harginine to 'H-citrulline under optimal conditions,20 and values were expressed as percentage of baseline activity (before drug injection). With 1 mg/kg of L-NAME, NO synthase activity was inhibited 67% at 1 hour and 31% at 4 hours (n= 1). With 5 mg/kg, activity was inhibited 100% at 1 hour and 85% at 4 hours (n=1). No further animals were administered 1 or 5 mg/kg because we wanted to find a dose that would consistently cause 100% inhibition of NO synthase activity. Using 10 mg/kg, activity was inhibited by 100% at both 1 and 4 hours (n=2). With these preliminary data we chose to use the 10-mg/kg dose in the remainder of the study.
For the injury protocol each cat randomly received either 10 mL of 0.9% saline (n=10) or 10 mg/kg of L-NAME in 0.9% saline 10 mL (n= 10) over 30 minutes by continuous intravenous infusion after baseline measurement. The microvascular clip was placed on the left MCA 30 minutes after saline or L-NAME administration. SEPs were measured before and at 30 minutes after saline or L-NAME and every 30 minutes during the 4-hour ischemia. Arterial blood gas and CBF measurements were made before and at 30 minutes after saline or L-NAME and at 30 minutes, 2, 3, and 4 hours after left MCA occlusion.
At 4 hours of ischemia, the cats were killed with intravenous potassium chloride. The brain was removed and cut immediately into 12 uniform coronal sections 3 mm thick. The freshly cut sections were immersed in a 1% solution of 2,3,5-triphenyltetrazolium chloride (TTC; Sigma Chemical Co, St Louis, Mo) in 0.9% saline at 37°C for 30 minutes and turned every 10 minutes. Viable brain areas appear dark red as a result of reduction of TTC by mitochondrial enzymes, whereas injured areas appear white.2122 Both sides of each section were photographed in color, and the areas of ischemic injury of the cerebral hemisphere and caudate nucleus were measured separately by digital planimetry.17"823 The areas of the anterior and posterior surfaces of each section were averaged. The product of this averaged area and the section thickness was calculated for each section, and the volume of injury was obtained by summing these products from all 12 sections. The slices of brain were placed in 10% buffered formalin for 1 to 2 days. Ipsilateral and contralateral temporal and parietal lobe of the middle four slices were subsequently sectioned into three cortical gray matter regions (inferior temporal, lateral temporal parietal, and superior parietal) and one white matter region. Injury volume within each of these areas was also recorded. Brain was also sectioned to determine regional CBF to the right and left caudate nucleus, right and left hippocampus, and posterior fossa (brain stem and cerebellum). The arterial reference samples and weighed tissue specimens were counted in a Packard multichannel autogamma scintillation spectrometer (model 5530, Minaxi, Downers Grove, Ill). The overlap of activity among isotopes was corrected by differential spectroscopy, and blood flow was calculated by the reference sample technique. '7-'9 Values are expressed as mean+SE. Statistical comparison to assess changes in measured physiological variables within groups was performed by analysis of injection at 1 hour and at 4 hours after drug adminisvariance. The effect of experimental manipulation on Results There were no differences between the two groups in baseline values of any physiological variables before the intravenous administration of saline or L-NAME (Table 1). Mean arterial blood pressure increased by 33+3% after L-NAME 10 mg/kg (P<.05) and was higher in the L-NAME group than in the saline group during 240 minutes of left MCA occlusion. Although Pao2 decreased slightly in both groups, values remained above 100 mm Hg. Other physiological variables were not affected by time and were comparable between groups during the experimental protocol.
Preischemia blood flow to caudate nucleus decreased after L-NAME but not after saline administration (Fig  1) . During 4 hours of MCA occlusion, blood flow to ipsilateral caudate nucleus was reduced to similar levels in both groups. In the contralateral caudate nucleus, blood flow remained lower in the L-NAME group, but flows were unchanged from the immediate preischemic values in the respective groups.
During left MCA occlusion, both groups demonstrated sustained reduction in blood flow to all ipsilateral structures except the hippocampus in the saline group. The greatest reduction in cortical CBF was in the inferior portion of the temporal lobe. The reduction was less in superior parietal cortex and intermediate in lateral cortex. There was no difference between groups in CBF in any ipsilateral region during ischemia except hippocampus, which demonstrated lower flow in L-NAME-treated cats (Table 2 ). Blood flow to contralateral regions and posterior fossa was not decreased by MCA occlusion. However, in each of these regions tP<.05 compared with saline-treated group. n=10, saline; n=10, L-NAME. Values are mean+SEM. L-NAME indicates Nt-nitro-L-arginine methyl ester; L-MCAO, left middle cerebral artery occlusion. n=10, saline; n=10, L-NAME. *P<.05 compared with pre-L-NAME value; tP<.05 compared with saline group. blood flow was decreased by L-NAME throughout the protocol (Table 2) .
Baseline amplitude (before saline, 105 + 15 ,V; before L-NAME, 105+13 ,uV) and latency (before saline, 12.6±0.3 milliseconds; before L-NAME, 12 .8+0.3 milliseconds) of the primary cortical SEP were not different between groups. Amplitude of the SEP was also not altered by saline or L-NAME (Fig 2) . During left MCA occlusion, ipsilateral SEP amplitudes were suppressed to the same extent (< 10% of baseline values) in the saline and L-NAME groups. However, SEP amplitude over the contralateral somatosensory cortex showed no change during 240 minutes of left MCA occlusion in both groups. In addition, all cats had normal latency of Values are mean±SEM. L-NAME indicates N1-nitro-L-arginine methyl ester. There was no difference between groups for any region.
Discussion
This study demonstrates that intravenous administration of L-NAME before prolonged MCA occlusion in cats results in protection from injury in the caudate nucleus but not in cerebral hemispheres. Protection from injury does not appear to be due to a favorable redistribution of blood flow during MCA occlusion in spite of increased arterial pressure. Decreased injury volume in L-NAME-pretreated cats was not associated with electrophysiological evidence of protection.
In rats, others have demonstrated that L-NAME (3 mg/kg but not 1 mg/kg) reduced the amount of brain injury resulting from permanent MCA occlusion. 24 Likewise, in mice, systemic administration of NG-nitro-L-arginine resulted in reduction in cerebral infarction from permanent MCA occlusion.6 However, in both studies efficacy of NO synthase inhibition was not determined, nor was there any attempt to control arterial blood gases that affect CBF. In the current study arterial blood gases and brain temperature were controlled and arterial pressure, SEPs, and regional CBF were monitored.
Although it is possible that L-NAME protected brain from injury by redistributing flow without an increase in Another possible explanation for the difference in therapeutic efficacy for L-NAME in caudate compared with cortex may be that blood flow to ipsilateral caudate nucleus during MCA occlusion was approximately 25 mL/min per 100 g in both L-NAME and saline groups, whereas in cortex blood flow was approximately 20 mL/min per 100 g in L-NAME-treated animals and 30 mL/min per 100 g in saline-treated animals. Since volume of injury in both cortex and caudate is inversely related to blood flow to that region, it is possible that cortical blood flow effects of L-NAME may have counteracted a potential beneficial effect on cortical parenchyma.
Focal ischemia is associated with excitatory amino acid-mediated brain injury.3435 The increase in excitatory amino acids stimulates both NMDA and non-NMDA glutamate receptors and is thought to stimulate NO synthase activity.13'36 Stimulation of NO synthase presumably results in increased NO production and neurotoxicity7 via a mechanism that has not been clearly elucidated37 but may involve an interaction of NO with superoxide anion.5'15 In a previous study18 we demonstrated an increase in flow during MCA occlusion in cats treated with conjugated superoxide dismutase, which was associated with decreased injury volume in caudate nucleus. Although it is possible that NO may be directly toxic to cells by reacting with nonheme iron-sulfur complex,37 this seems unlikely because NO is also a natural mediator of vasodilation for agents that act via an endothelial-dependent process.' Nonetheless, both NO and excitatory amino acids appear to be linked to the mechanism of injury after focal cerebral ischemia.6 '38 An alternative explanation for protection by L-NAME may be via an effect on cerebral metabolism. For example, other drugs (eg, barbiturates) that decrease cerebral metabolism have been demonstrated to an unlikely mechanism for the beneficial effects of L-NAME because we have previously demonstrated reduced CBF during inhibition of NO synthase activity without a decrease in 02 consumption. 25 Inhibition of NO synthase activity may not be protective in all types of ischemia. Indeed, in gerbils systemic administration of L-NAME resulted in delayed electrocortical recovery after transient forebrain ischemia. 40 However, efficacy of NO synthase inhibition was not determined, and physiological variables were not recorded. These authors also did not determine the effect of L-NAME on electrocortical activity in control animals to determine baseline effects. In our study, the lack of effect of L-NAME on SEPs during 4 hours of ischemia may be related to the lack of effect on hemispheric injury volume. This is consistent with the correlation that has been demonstrated between cortical injury and SEPs.18 '4' More recently, others have demonstrated that administration of Nr-nitro-L-arginine to spontaneously hypertensive rats was associated with a worsening of cortical injury volume after MCA occlusion.42 Furthermore, in this study the detrimental effect of NO synthase inhibition could be prevented with L-arginine but not D-arginine. 42 Unlike cats in our study and normotensive rats in other studies,43 inhibition of NO synthase in hypertensive rats42 did not appear to reduce CBF. This observation suggests a different effect of NO synthase inhibition on brain in spontaneously hypertensive rats.
Injury volume was estimated with TTC staining. TTC acts as a proton acceptor for mitochondrial oxidative cellular metabolism. 44 When compared with light microscopy TTC tended to overestimate ischemic volumes of hemispheres and cortex and underestimate ischemic volume in caudate for rat exposed to 4 hours of MCA occlusion. 45 The rationale for using a 4-hour period of ischemia was to obtain an early indicator of injury and to avoid potential detrimental effects of prolonged halothane anesthesia during MCA occlusion. In another study TTC staining was found to correlate with histopathology best in cats when the time of ischemia was greater than 2 hours and there was at least 2 hours of reperfusion. 46 The mechanism for reduction of CBF with L-NAME protect brain during focal ischemia. 39 We believe this is appears to be related to decreased tonic release of NO. In conclusion, these data indicate that L-NAME treatment before 4 hours of focal ischemia can alleviate acute neuronal injury of caudate nucleus in cats anesthetized with halothane. Our data support the hypothesis that NO may be important in the mechanism of brain injury from focal ischemia. However, because we did not also find protection in cerebral cortex, we cannot exclude other mechanisms that are specific for the caudate nucleus.
